Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Frampas

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Oncotarget|June 26, 2018
Sensitivity of pretargeted immunoPET using <sup>68</sup>Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with <sup>18</sup>FDG PET-CTFanny Foubert, Sébastien Gouard, Catherine Saï-Maurel, et al.
Seminars in Oncology|December 3, 2014
Radioimmunoconjugates for the treatment of cancerFrançoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Rousseau, et al.
Frontiers in Medicine|June 20, 2019
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic ApproachesCaroline Bodet-Milin, Clément Bailly, Yann Touchefeu, et al.
Clinical Nuclear Medicine|December 14, 2020
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine TumorsCatherine Ansquer, Yann Touchefeu, Alain Faivre-Chauvet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR IndexMarion Schaefer, Valérie Laurent, Aurélie Grandmougin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC StudyCaroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 3, 2020
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Louis de Mestier, Come Lepage, Eric Baudin, et al.
Crohn'S & Colitis 360|February 13, 2023
Development of a New Index to Assess Small Bowel Inflammation Severity in Crohn's Disease Using Magnetic Resonance EnterographyYoram Bouhnik, Catherine Le Berre, Magaly Zappa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2014
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinomaPierre-Yves Salaun, Loïc Campion, Catherine Ansquer, et al.
Diagnostic and Interventional Imaging|July 24, 2024
Detection and characterization of pancreatic lesion with artificial intelligence: The SFR 2023 artificial intelligence data challengeTheodore Aouad, Valerie Laurent, Paul Levant, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Oncotarget|June 26, 2018
Sensitivity of pretargeted immunoPET using <sup>68</sup>Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with <sup>18</sup>FDG PET-CTFanny Foubert, Sébastien Gouard, Catherine Saï-Maurel, et al.
Seminars in Oncology|December 3, 2014
Radioimmunoconjugates for the treatment of cancerFrançoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Rousseau, et al.
Frontiers in Medicine|June 20, 2019
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic ApproachesCaroline Bodet-Milin, Clément Bailly, Yann Touchefeu, et al.
Clinical Nuclear Medicine|December 14, 2020
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine TumorsCatherine Ansquer, Yann Touchefeu, Alain Faivre-Chauvet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR IndexMarion Schaefer, Valérie Laurent, Aurélie Grandmougin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC StudyCaroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 3, 2020
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Louis de Mestier, Come Lepage, Eric Baudin, et al.
Crohn'S & Colitis 360|February 13, 2023
Development of a New Index to Assess Small Bowel Inflammation Severity in Crohn's Disease Using Magnetic Resonance EnterographyYoram Bouhnik, Catherine Le Berre, Magaly Zappa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2014
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinomaPierre-Yves Salaun, Loïc Campion, Catherine Ansquer, et al.
Diagnostic and Interventional Imaging|July 24, 2024
Detection and characterization of pancreatic lesion with artificial intelligence: The SFR 2023 artificial intelligence data challengeTheodore Aouad, Valerie Laurent, Paul Levant, et al.
Pageof 6